APO Research
Talk to an analyst

APO RESEARCH · REPORT

Custom Plasmid Production and Manufacturing

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Custom Plasmid Production and Manufacturing Market Analysis and Forecast 2026-2032

5 June 2026259 pages

Choose your research edition.

Industry ResearchCustom Plasmid Production and Manufacturing Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Custom Plasmid Production and Manufacturing Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Custom Plasmid Production and Manufacturing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Custom Plasmid Production and Manufacturing Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Custom Plasmid Production and Manufacturing Market Analysis and Forecast 2026-2032259 pages · $4,950 USD

Market perspective

The global Custom Plasmid Production and Manufacturing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Custom Plasmid Production and Manufacturing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Custom Plasmid Production and Manufacturing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Custom Plasmid Production and Manufacturing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Custom Plasmid Production and Manufacturing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Custom Plasmid Production and Manufacturing include Aldevron, Catalent Biologics, Polyplus, Creative Biogene, PlasmidFactory GmbH, Bionexus, Wuxi Advanced Therapies, Charles River Laboratories and Plasmid Biosciences, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Custom Plasmid Production and Manufacturing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Custom Plasmid Production and Manufacturing, also provides the revenue of main regions and countries. Of the upcoming market potential for Custom Plasmid Production and Manufacturing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Custom Plasmid Production and Manufacturing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Custom Plasmid Production and Manufacturing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Custom Plasmid Production and Manufacturing revenue, projected growth trends, production technology, application and end-user industry.

Custom Plasmid Production and Manufacturing Segment by Company

Aldevron

Catalent Biologics

Polyplus

Creative Biogene

PlasmidFactory GmbH

Bionexus

Wuxi Advanced Therapies

Charles River Laboratories

Plasmid Biosciences

Sartorius AG

Porton Advanced

Oxford Genetics LTD

uBriGene

TriLink BioTechnologies

Vectorbuilder

Custom Plasmid Production and Manufacturing Segment by Type

Research Grade

Industrial Grade

GMP Grade

Others

Custom Plasmid Production and Manufacturing Segment by Application

Gene Therapy

Basic Research

Drug Development

Others

Custom Plasmid Production and Manufacturing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom Plasmid Production and Manufacturing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Custom Plasmid Production and Manufacturing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom Plasmid Production and Manufacturing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Custom Plasmid Production and Manufacturing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Custom Plasmid Production and Manufacturing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Custom Plasmid Production and Manufacturing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Custom Plasmid Production and Manufacturing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Research Grade Major Player Table 3. Industrial Grade Major Player Table 4. GMP Grade Major Player Table 5. Others Major Player Table 6. Global Custom Plasmid Production and Manufacturing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Gene Therapy Major Player Table 8. Basic Research Major Player Table 9. Drug Development Major Player Table 10. Others Major Player Table 11. Custom Plasmid Production and Manufacturing Industry Trends Table 12. Custom Plasmid Production and Manufacturing Industry Drivers Table 13. Custom Plasmid Production and Manufacturing Industry Opportunities and Challenges Table 14. Custom Plasmid Production and Manufacturing Industry Restraints Table 15. Global Custom Plasmid Production and Manufacturing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Custom Plasmid Production and Manufacturing Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Custom Plasmid Production and Manufacturing Market Share by Region (2021-2026) Table 18. Global Custom Plasmid Production and Manufacturing Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Custom Plasmid Production and Manufacturing Market Share by Region (2027-2032) Table 20. Global Custom Plasmid Production and Manufacturing Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Custom Plasmid Production and Manufacturing Revenue Market Share by Players (2021-2026) Table 22. Global Custom Plasmid Production and Manufacturing Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Custom Plasmid Production and Manufacturing Key Players Headquarters & Area Served Table 24. Global Custom Plasmid Production and Manufacturing Players, Product Type & Application Table 25. Global Custom Plasmid Production and Manufacturing Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Custom Plasmid Production and Manufacturing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Custom Plasmid Production and Manufacturing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Custom Plasmid Production and Manufacturing Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Custom Plasmid Production and Manufacturing Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Custom Plasmid Production and Manufacturing Revenue Market Share by Type (2021-2026) Table 32. Global Custom Plasmid Production and Manufacturing Revenue Market Share by Type (2027-2032) Table 33. Global Custom Plasmid Production and Manufacturing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Custom Plasmid Production and Manufacturing Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Custom Plasmid Production and Manufacturing Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Custom Plasmid Production and Manufacturing Revenue Market Share by Application (2021-2026) Table 37. Global Custom Plasmid Production and Manufacturing Revenue Market Share by Application (2027-2032) Table 38. Aldevron Company Information Table 39. Aldevron Business Overview Table 40. Aldevron Custom Plasmid Production and Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Aldevron Custom Plasmid Production and Manufacturing Product Portfolio Table 42. Aldevron Recent Development Table 43. Catalent Biologics Company Information Table 44. Catalent Biologics Business Overview Table 45. Catalent Biologics Custom Plasmid Production and Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Catalent Biologics Custom Plasmid Production and Manufacturing Product Portfolio Table 47. Catalent Biologics Recent Development Table 48. Polyplus Company Information Table 49. Polyplus Business Overview Table 50. Polyplus Custom Plasmid Production and Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Polyplus Custom Plasmid Production and Manufacturing Product Portfolio Table 52. Polyplus Recent Development Table 53. Creative Biogene Company Information Table 54. Creative Biogene Business Overview Table 55. Creative Biogene Custom Plasmid Production and Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Creative Biogene Custom Plasmid Production and Manufacturing Product Portfolio Table 57. Creative Biogene Recent Development Table 58. PlasmidFactory GmbH Company Information Table 59. PlasmidFactory GmbH Business Overview Table 60. PlasmidFactory GmbH Custom Plasmid Production and Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. PlasmidFactory GmbH Custom Plasmid Production and Manufacturing Product Portfolio Table 62. PlasmidFactory GmbH Recent Development Table 63. Bionexus Company Information Table 64. Bionexus Business Overview Table 65. Bionexus Custom Plasmid Production and Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Bionexus Custom Plasmid Production and Manufacturing Product Portfolio Table 67. Bionexus Recent Development Table 68. Wuxi Advanced Therapies Company Information Table 69. Wuxi Advanced Therapies Business Overview Table 70. Wuxi Advanced Therapies Custom Plasmid Production and Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Wuxi Advanced Therapies Custom Plasmid Production and Manufacturing Product Portfolio Table 72. Wuxi Advanced Therapies Recent Development Table 73. Charles River Laboratories Company Information Table 74. Charles River Laboratories Business Overview Table 75. Charles River Laboratories Custom Plasmid Production and Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Charles River Laboratories Custom Plasmid Production and Manufacturing Product Portfolio Table 77. Charles River Laboratories Recent Development Table 78. Plasmid Biosciences Company Information Table 79. Plasmid Biosciences Business Overview Table 80. Plasmid Biosciences Custom Plasmid Production and Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Plasmid Biosciences Custom Plasmid Production and Manufacturing Product Portfolio Table 82. Plasmid Biosciences Recent Development Table 83. Sartorius AG Company Information Table 84. Sartorius AG Business Overview Table 85. Sartorius AG Custom Plasmid Production and Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Sartorius AG Custom Plasmid Production and Manufacturing Product Portfolio Table 87. Sartorius AG Recent Development Table 88. Porton Advanced Company Information Table 89. Porton Advanced Business Overview Table 90. Porton Advanced Custom Plasmid Production and Manufacturing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Porton Advanced Custom Plasmid Production and Manufacturing Product Portfolio Table 92. Porton Advanced Recent Development Table 93. Oxford Genetics LTD Company Information Table 94. Oxford Genetics LTD Business Overview Table 95. Oxford Genetics LTD Custom Plasmid Production and Manufacturing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Oxford Genetics LTD Custom Plasmid Production and Manufacturing Product Portfolio Table 97. Oxford Genetics LTD Recent Development Table 98. uBriGene Company Information Table 99. uBriGene Business Overview Table 100. uBriGene Custom Plasmid Production and Manufacturing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. uBriGene Custom Plasmid Production and Manufacturing Product Portfolio Table 102. uBriGene Recent Development Table 103. TriLink BioTechnologies Company Information Table 104. TriLink BioTechnologies Business Overview Table 105. TriLink BioTechnologies Custom Plasmid Production and Manufacturing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. TriLink BioTechnologies Custom Plasmid Production and Manufacturing Product Portfolio Table 107. TriLink BioTechnologies Recent Development Table 108. Vectorbuilder Company Information Table 109. Vectorbuilder Business Overview Table 110. Vectorbuilder Custom Plasmid Production and Manufacturing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Vectorbuilder Custom Plasmid Production and Manufacturing Product Portfolio Table 112. Vectorbuilder Recent Development Table 113. North America Custom Plasmid Production and Manufacturing Revenue by Type (2021-2026) & (US$ Million) Table 114. North America Custom Plasmid Production and Manufacturing Revenue by Type (2027-2032) & (US$ Million) Table 115. North America Custom Plasmid Production and Manufacturing Revenue by Application (2021-2026) & (US$ Million) Table 116. North America Custom Plasmid Production and Manufacturing Revenue by Application (2027-2032) & (US$ Million) Table 117. North America Custom Plasmid Production and Manufacturing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. North America Custom Plasmid Production and Manufacturing Revenue by Country (2021-2026) & (US$ Million) Table 119. North America Custom Plasmid Production and Manufacturing Revenue by Country (US$ Million) & (2027-2032) Table 120. Europe Custom Plasmid Production and Manufacturing Revenue by Type (2021-2026) & (US$ Million) Table 121. Europe Custom Plasmid Production and Manufacturing Revenue by Type (2027-2032) & (US$ Million) Table 122. Europe Custom Plasmid Production and Manufacturing Revenue by Application (2021-2026) & (US$ Million) Table 123. Europe Custom Plasmid Production and Manufacturing Revenue by Application (2027-2032) & (US$ Million) Table 124. Europe Custom Plasmid Production and Manufacturing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. Europe Custom Plasmid Production and Manufacturing Revenue by Country (2021-2026) & (US$ Million) Table 126. Europe Custom Plasmid Production and Manufacturing Revenue by Country (US$ Million) & (2027-2032) Table 127. China Custom Plasmid Production and Manufacturing Revenue by Type (2021-2026) & (US$ Million) Table 128. China Custom Plasmid Production and Manufacturing Revenue by Type (2027-2032) & (US$ Million) Table 129. China Custom Plasmid Production and Manufacturing Revenue by Application (2021-2026) & (US$ Million) Table 130. China Custom Plasmid Production and Manufacturing Revenue by Application (2027-2032) & (US$ Million) Table 131. Asia Custom Plasmid Production and Manufacturing Revenue by Type (2021-2026) & (US$ Million) Table 132. Asia Custom Plasmid Production and Manufacturing Revenue by Type (2027-2032) & (US$ Million) Table 133. Asia Custom Plasmid Production and Manufacturing Revenue by Application (2021-2026) & (US$ Million) Table 134. Asia Custom Plasmid Production and Manufacturing Revenue by Application (2027-2032) & (US$ Million) Table 135. Asia Custom Plasmid Production and Manufacturing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 136. Asia Custom Plasmid Production and Manufacturing Revenue by Region (US$ Million) & (2021-2026) Table 137. Asia Custom Plasmid Production and Manufacturing Revenue by Region (US$ Million) & (2027-2032) Table 138. SAMEA Custom Plasmid Production and Manufacturing Revenue by Type (2021-2026) & (US$ Million) Table 139. SAMEA Custom Plasmid Production and Manufacturing Revenue by Type (2027-2032) & (US$ Million) Table 140. SAMEA Custom Plasmid Production and Manufacturing Revenue by Application (2021-2026) & (US$ Million) Table 141. SAMEA Custom Plasmid Production and Manufacturing Revenue by Application (2027-2032) & (US$ Million) Table 142. SAMEA Custom Plasmid Production and Manufacturing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. SAMEA Custom Plasmid Production and Manufacturing Revenue by Country (2021-2026) & (US$ Million) Table 144. SAMEA Custom Plasmid Production and Manufacturing Revenue by Country (US$ Million) & (2027-2032) Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Custom Plasmid Production and Manufacturing Image Figure 2. Global Custom Plasmid Production and Manufacturing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Custom Plasmid Production and Manufacturing Market Size Share 2021 VS 2025 VS 2032 Figure 4. Research Grade Image Figure 5. Industrial Grade Image Figure 6. GMP Grade Image Figure 7. Others Image Figure 8. Global Custom Plasmid Production and Manufacturing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Custom Plasmid Production and Manufacturing Market Size Share 2021 VS 2025 VS 2032 Figure 10. Gene Therapy Image Figure 11. Basic Research Image Figure 12. Drug Development Image Figure 13. Others Image Figure 14. Global Custom Plasmid Production and Manufacturing Market Size (US$ Million) & (2021-2032) Figure 15. Global Custom Plasmid Production and Manufacturing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Custom Plasmid Production and Manufacturing Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Custom Plasmid Production and Manufacturing Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Custom Plasmid Production and Manufacturing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Custom Plasmid Production and Manufacturing Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Custom Plasmid Production and Manufacturing Revenue Market Share by Type (2021-2032) Figure 22. Global Custom Plasmid Production and Manufacturing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Custom Plasmid Production and Manufacturing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Custom Plasmid Production and Manufacturing Revenue Market Share by Application (2021-2032) Figure 25. North America Custom Plasmid Production and Manufacturing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Custom Plasmid Production and Manufacturing Revenue Share by Type (2021-2032) Figure 27. North America Custom Plasmid Production and Manufacturing Revenue Share by Application (2021-2032) Figure 28. North America Custom Plasmid Production and Manufacturing Revenue Share by Country (2021-2032) Figure 29. United States Custom Plasmid Production and Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Custom Plasmid Production and Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Custom Plasmid Production and Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Custom Plasmid Production and Manufacturing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Custom Plasmid Production and Manufacturing Revenue Share by Type (2021-2032) Figure 34. Europe Custom Plasmid Production and Manufacturing Revenue Share by Application (2021-2032) Figure 35. Europe Custom Plasmid Production and Manufacturing Revenue Share by Country (2021-2032) Figure 36. Germany Custom Plasmid Production and Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Custom Plasmid Production and Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Custom Plasmid Production and Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Custom Plasmid Production and Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Custom Plasmid Production and Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Custom Plasmid Production and Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Custom Plasmid Production and Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Custom Plasmid Production and Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Custom Plasmid Production and Manufacturing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Custom Plasmid Production and Manufacturing Revenue Share by Type (2021-2032) Figure 46. China Custom Plasmid Production and Manufacturing Revenue Share by Application (2021-2032) Figure 47. Asia Custom Plasmid Production and Manufacturing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Custom Plasmid Production and Manufacturing Revenue Share by Type (2021-2032) Figure 49. Asia Custom Plasmid Production and Manufacturing Revenue Share by Application (2021-2032) Figure 50. Asia Custom Plasmid Production and Manufacturing Revenue Share by Region (2021-2032) Figure 51. Japan Custom Plasmid Production and Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Custom Plasmid Production and Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Custom Plasmid Production and Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Custom Plasmid Production and Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Custom Plasmid Production and Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Custom Plasmid Production and Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Custom Plasmid Production and Manufacturing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Custom Plasmid Production and Manufacturing Revenue Share by Type (2021-2032) Figure 59. SAMEA Custom Plasmid Production and Manufacturing Revenue Share by Application (2021-2032) Figure 60. SAMEA Custom Plasmid Production and Manufacturing Revenue Share by Country (2021-2032) Figure 61. Brazil Custom Plasmid Production and Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Custom Plasmid Production and Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Custom Plasmid Production and Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Custom Plasmid Production and Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Custom Plasmid Production and Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Custom Plasmid Production and Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Custom Plasmid Production and Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Custom Plasmid Production and Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Custom Plasmid Production and Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Custom Plasmid Production and Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Custom Plasmid Production and Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Research Grade
  • Industrial Grade
  • GMP Grade
  • Others
Applications
  • Gene Therapy
  • Basic Research
  • Drug Development
  • Others
Companies covered
  • Aldevron
  • Catalent Biologics
  • Polyplus
  • Creative Biogene
  • PlasmidFactory GmbH
  • Bionexus
  • Wuxi Advanced Therapies
  • Charles River Laboratories
  • Plasmid Biosciences
  • Sartorius AG
  • Porton Advanced
  • Oxford Genetics LTD
  • uBriGene
  • TriLink BioTechnologies
  • Vectorbuilder

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Custom Plasmid Production and Manufacturing Market by Type
  3. 1.2.1 Global Custom Plasmid Production and Manufacturing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Research Grade
  5. 1.2.3 Industrial Grade
  6. 1.2.4 GMP Grade
  7. 1.2.5 Others
  8. 1.3 Custom Plasmid Production and Manufacturing Market by Application
  9. 1.3.1 Global Custom Plasmid Production and Manufacturing Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Gene Therapy
  11. 1.3.3 Basic Research
  12. 1.3.4 Drug Development
  13. 1.3.5 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Custom Plasmid Production and Manufacturing Market Dynamics
  1. 2.1 Custom Plasmid Production and Manufacturing Industry Trends
  2. 2.2 Custom Plasmid Production and Manufacturing Industry Drivers
  3. 2.3 Custom Plasmid Production and Manufacturing Industry Opportunities and Challenges
  4. 2.4 Custom Plasmid Production and Manufacturing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Custom Plasmid Production and Manufacturing Market Perspective (2021-2032)
  2. 3.2 Global Custom Plasmid Production and Manufacturing Growth Trends by Region
  3. 3.2.1 Global Custom Plasmid Production and Manufacturing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Custom Plasmid Production and Manufacturing Market Size by Region (2021-2026)
  5. 3.2.3 Global Custom Plasmid Production and Manufacturing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Custom Plasmid Production and Manufacturing Revenue by Players
  2. 4.1.1 Global Custom Plasmid Production and Manufacturing Revenue by Players (2021-2026)
  3. 4.1.2 Global Custom Plasmid Production and Manufacturing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Custom Plasmid Production and Manufacturing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Custom Plasmid Production and Manufacturing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Custom Plasmid Production and Manufacturing Key Players Headquarters & Area Served
  7. 4.4 Global Custom Plasmid Production and Manufacturing Players, Product Type & Application
  8. 4.5 Global Custom Plasmid Production and Manufacturing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Custom Plasmid Production and Manufacturing Market CR5 and HHI
  11. 4.6.3 2025 Custom Plasmid Production and Manufacturing Tier 1, Tier 2, and Tier 3
5 Custom Plasmid Production and Manufacturing Market Size by Type
  1. 5.1 Global Custom Plasmid Production and Manufacturing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Custom Plasmid Production and Manufacturing Revenue by Type (2021-2032)
  3. 5.3 Global Custom Plasmid Production and Manufacturing Revenue Market Share by Type (2021-2032)
6 Custom Plasmid Production and Manufacturing Market Size by Application
  1. 6.1 Global Custom Plasmid Production and Manufacturing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Custom Plasmid Production and Manufacturing Revenue by Application (2021-2032)
  3. 6.3 Global Custom Plasmid Production and Manufacturing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Aldevron
  2. 7.1.1 Aldevron Company Information
  3. 7.1.2 Aldevron Business Overview
  4. 7.1.3 Aldevron Custom Plasmid Production and Manufacturing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Aldevron Custom Plasmid Production and Manufacturing Product Portfolio
  6. 7.1.5 Aldevron Recent Developments
  7. 7.2 Catalent Biologics
  8. 7.2.1 Catalent Biologics Company Information
  9. 7.2.2 Catalent Biologics Business Overview
  10. 7.2.3 Catalent Biologics Custom Plasmid Production and Manufacturing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Catalent Biologics Custom Plasmid Production and Manufacturing Product Portfolio
  12. 7.2.5 Catalent Biologics Recent Developments
  13. 7.3 Polyplus
  14. 7.3.1 Polyplus Company Information
  15. 7.3.2 Polyplus Business Overview
  16. 7.3.3 Polyplus Custom Plasmid Production and Manufacturing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Polyplus Custom Plasmid Production and Manufacturing Product Portfolio
  18. 7.3.5 Polyplus Recent Developments
  19. 7.4 Creative Biogene
  20. 7.4.1 Creative Biogene Company Information
  21. 7.4.2 Creative Biogene Business Overview
  22. 7.4.3 Creative Biogene Custom Plasmid Production and Manufacturing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Creative Biogene Custom Plasmid Production and Manufacturing Product Portfolio
  24. 7.4.5 Creative Biogene Recent Developments
  25. 7.5 PlasmidFactory GmbH
  26. 7.5.1 PlasmidFactory GmbH Company Information
  27. 7.5.2 PlasmidFactory GmbH Business Overview
  28. 7.5.3 PlasmidFactory GmbH Custom Plasmid Production and Manufacturing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 PlasmidFactory GmbH Custom Plasmid Production and Manufacturing Product Portfolio
  30. 7.5.5 PlasmidFactory GmbH Recent Developments
  31. 7.6 Bionexus
  32. 7.6.1 Bionexus Company Information
  33. 7.6.2 Bionexus Business Overview
  34. 7.6.3 Bionexus Custom Plasmid Production and Manufacturing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Bionexus Custom Plasmid Production and Manufacturing Product Portfolio
  36. 7.6.5 Bionexus Recent Developments
  37. 7.7 Wuxi Advanced Therapies
  38. 7.7.1 Wuxi Advanced Therapies Company Information
  39. 7.7.2 Wuxi Advanced Therapies Business Overview
  40. 7.7.3 Wuxi Advanced Therapies Custom Plasmid Production and Manufacturing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Wuxi Advanced Therapies Custom Plasmid Production and Manufacturing Product Portfolio
  42. 7.7.5 Wuxi Advanced Therapies Recent Developments
  43. 7.8 Charles River Laboratories
  44. 7.8.1 Charles River Laboratories Company Information
  45. 7.8.2 Charles River Laboratories Business Overview
  46. 7.8.3 Charles River Laboratories Custom Plasmid Production and Manufacturing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Charles River Laboratories Custom Plasmid Production and Manufacturing Product Portfolio
  48. 7.8.5 Charles River Laboratories Recent Developments
  49. 7.9 Plasmid Biosciences
  50. 7.9.1 Plasmid Biosciences Company Information
  51. 7.9.2 Plasmid Biosciences Business Overview
  52. 7.9.3 Plasmid Biosciences Custom Plasmid Production and Manufacturing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Plasmid Biosciences Custom Plasmid Production and Manufacturing Product Portfolio
  54. 7.9.5 Plasmid Biosciences Recent Developments
  55. 7.10 Sartorius AG
  56. 7.10.1 Sartorius AG Company Information
  57. 7.10.2 Sartorius AG Business Overview
  58. 7.10.3 Sartorius AG Custom Plasmid Production and Manufacturing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Sartorius AG Custom Plasmid Production and Manufacturing Product Portfolio
  60. 7.10.5 Sartorius AG Recent Developments
  61. 7.11 Porton Advanced
  62. 7.11.1 Porton Advanced Company Information
  63. 7.11.2 Porton Advanced Business Overview
  64. 7.11.3 Porton Advanced Custom Plasmid Production and Manufacturing Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Porton Advanced Custom Plasmid Production and Manufacturing Product Portfolio
  66. 7.11.5 Porton Advanced Recent Developments
  67. 7.12 Oxford Genetics LTD
  68. 7.12.1 Oxford Genetics LTD Company Information
  69. 7.12.2 Oxford Genetics LTD Business Overview
  70. 7.12.3 Oxford Genetics LTD Custom Plasmid Production and Manufacturing Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Oxford Genetics LTD Custom Plasmid Production and Manufacturing Product Portfolio
  72. 7.12.5 Oxford Genetics LTD Recent Developments
  73. 7.13 uBriGene
  74. 7.13.1 uBriGene Company Information
  75. 7.13.2 uBriGene Business Overview
  76. 7.13.3 uBriGene Custom Plasmid Production and Manufacturing Revenue and Gross Margin (2021-2026)
  77. 7.13.4 uBriGene Custom Plasmid Production and Manufacturing Product Portfolio
  78. 7.13.5 uBriGene Recent Developments
  79. 7.14 TriLink BioTechnologies
  80. 7.14.1 TriLink BioTechnologies Company Information
  81. 7.14.2 TriLink BioTechnologies Business Overview
  82. 7.14.3 TriLink BioTechnologies Custom Plasmid Production and Manufacturing Revenue and Gross Margin (2021-2026)
  83. 7.14.4 TriLink BioTechnologies Custom Plasmid Production and Manufacturing Product Portfolio
  84. 7.14.5 TriLink BioTechnologies Recent Developments
  85. 7.15 Vectorbuilder
  86. 7.15.1 Vectorbuilder Company Information
  87. 7.15.2 Vectorbuilder Business Overview
  88. 7.15.3 Vectorbuilder Custom Plasmid Production and Manufacturing Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Vectorbuilder Custom Plasmid Production and Manufacturing Product Portfolio
  90. 7.15.5 Vectorbuilder Recent Developments
8 North America
  1. 8.1 North America Custom Plasmid Production and Manufacturing Revenue (2021-2032)
  2. 8.2 North America Custom Plasmid Production and Manufacturing Revenue by Type (2021-2032)
  3. 8.2.1 North America Custom Plasmid Production and Manufacturing Revenue by Type (2021-2026)
  4. 8.2.2 North America Custom Plasmid Production and Manufacturing Revenue by Type (2027-2032)
  5. 8.3 North America Custom Plasmid Production and Manufacturing Revenue Share by Type (2021-2032)
  6. 8.4 North America Custom Plasmid Production and Manufacturing Revenue by Application (2021-2032)
  7. 8.4.1 North America Custom Plasmid Production and Manufacturing Revenue by Application (2021-2026)
  8. 8.4.2 North America Custom Plasmid Production and Manufacturing Revenue by Application (2027-2032)
  9. 8.5 North America Custom Plasmid Production and Manufacturing Revenue Share by Application (2021-2032)
  10. 8.6 North America Custom Plasmid Production and Manufacturing Revenue by Country
  11. 8.6.1 North America Custom Plasmid Production and Manufacturing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Custom Plasmid Production and Manufacturing Revenue by Country (2021-2026)
  13. 8.6.3 North America Custom Plasmid Production and Manufacturing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Custom Plasmid Production and Manufacturing Revenue (2021-2032)
  2. 9.2 Europe Custom Plasmid Production and Manufacturing Revenue by Type (2021-2032)
  3. 9.2.1 Europe Custom Plasmid Production and Manufacturing Revenue by Type (2021-2026)
  4. 9.2.2 Europe Custom Plasmid Production and Manufacturing Revenue by Type (2027-2032)
  5. 9.3 Europe Custom Plasmid Production and Manufacturing Revenue Share by Type (2021-2032)
  6. 9.4 Europe Custom Plasmid Production and Manufacturing Revenue by Application (2021-2032)
  7. 9.4.1 Europe Custom Plasmid Production and Manufacturing Revenue by Application (2021-2026)
  8. 9.4.2 Europe Custom Plasmid Production and Manufacturing Revenue by Application (2027-2032)
  9. 9.5 Europe Custom Plasmid Production and Manufacturing Revenue Share by Application (2021-2032)
  10. 9.6 Europe Custom Plasmid Production and Manufacturing Revenue by Country
  11. 9.6.1 Europe Custom Plasmid Production and Manufacturing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Custom Plasmid Production and Manufacturing Revenue by Country (2021-2026)
  13. 9.6.3 Europe Custom Plasmid Production and Manufacturing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Custom Plasmid Production and Manufacturing Revenue (2021-2032)
  2. 10.2 China Custom Plasmid Production and Manufacturing Revenue by Type (2021-2032)
  3. 10.2.1 China Custom Plasmid Production and Manufacturing Revenue by Type (2021-2026)
  4. 10.2.2 China Custom Plasmid Production and Manufacturing Revenue by Type (2027-2032)
  5. 10.3 China Custom Plasmid Production and Manufacturing Revenue Share by Type (2021-2032)
  6. 10.4 China Custom Plasmid Production and Manufacturing Revenue by Application (2021-2032)
  7. 10.4.1 China Custom Plasmid Production and Manufacturing Revenue by Application (2021-2026)
  8. 10.4.2 China Custom Plasmid Production and Manufacturing Revenue by Application (2027-2032)
  9. 10.5 China Custom Plasmid Production and Manufacturing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Custom Plasmid Production and Manufacturing Revenue (2021-2032)
  2. 11.2 Asia Custom Plasmid Production and Manufacturing Revenue by Type (2021-2032)
  3. 11.2.1 Asia Custom Plasmid Production and Manufacturing Revenue by Type (2021-2026)
  4. 11.2.2 Asia Custom Plasmid Production and Manufacturing Revenue by Type (2027-2032)
  5. 11.3 Asia Custom Plasmid Production and Manufacturing Revenue Share by Type (2021-2032)
  6. 11.4 Asia Custom Plasmid Production and Manufacturing Revenue by Application (2021-2032)
  7. 11.4.1 Asia Custom Plasmid Production and Manufacturing Revenue by Application (2021-2026)
  8. 11.4.2 Asia Custom Plasmid Production and Manufacturing Revenue by Application (2027-2032)
  9. 11.5 Asia Custom Plasmid Production and Manufacturing Revenue Share by Application (2021-2032)
  10. 11.6 Asia Custom Plasmid Production and Manufacturing Revenue by Country
  11. 11.6.1 Asia Custom Plasmid Production and Manufacturing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Custom Plasmid Production and Manufacturing Revenue by Country (2021-2026)
  13. 11.6.3 Asia Custom Plasmid Production and Manufacturing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Custom Plasmid Production and Manufacturing Revenue (2021-2032)
  2. 12.2 SAMEA Custom Plasmid Production and Manufacturing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Custom Plasmid Production and Manufacturing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Custom Plasmid Production and Manufacturing Revenue by Type (2027-2032)
  5. 12.3 SAMEA Custom Plasmid Production and Manufacturing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Custom Plasmid Production and Manufacturing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Custom Plasmid Production and Manufacturing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Custom Plasmid Production and Manufacturing Revenue by Application (2027-2032)
  9. 12.5 SAMEA Custom Plasmid Production and Manufacturing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Custom Plasmid Production and Manufacturing Revenue by Country
  11. 12.6.1 SAMEA Custom Plasmid Production and Manufacturing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Custom Plasmid Production and Manufacturing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Custom Plasmid Production and Manufacturing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst